Answers are grounded in this paper and cite their sources.
Echinocandins are front-line agents for treatment of invasive candidiasis. There are no reported agent-specific differences in Candida mutational frequency of resistance or propensity to develop FKS mutations.
No takes yet. Share an insight, caveat, or question.
Shields et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: